114 related articles for article (PubMed ID: 25264825)
1. Modulation of cAMP-specific PDE without emetogenic activity: new sulfide-like PDE7 inhibitors.
García AM; Brea J; Morales-García JA; Perez DI; González A; Alonso-Gil S; Gracia-Rubio I; Ros-Simó C; Conde S; Cadavid MI; Loza MI; Perez-Castillo A; Valverde O; Martinez A; Gil C
J Med Chem; 2014 Oct; 57(20):8590-607. PubMed ID: 25264825
[TBL] [Abstract][Full Text] [Related]
2. Microwave-assisted synthesis of potent PDE7 inhibitors containing a thienopyrimidin-4-amine scaffold.
Sánchez AI; Meneses R; Mínguez JM; Núñez A; Castillo RR; Filace F; Burgos C; Vaquero JJ; Álvarez-Builla J; Cortés-Cabrera A; Gago F; Terricabras E; Segarra V
Org Biomol Chem; 2014 Jun; 12(24):4233-42. PubMed ID: 24838636
[TBL] [Abstract][Full Text] [Related]
3. Effect of phosphodiesterase 7 (PDE7) inhibitors in experimental autoimmune encephalomyelitis mice. Discovery of a new chemically diverse family of compounds.
Redondo M; Brea J; Perez DI; Soteras I; Val C; Perez C; Morales-García JA; Alonso-Gil S; Paul-Fernandez N; Martin-Alvarez R; Cadavid MI; Loza MI; Perez-Castillo A; Mengod G; Campillo NE; Martinez A; Gil C
J Med Chem; 2012 Apr; 55(7):3274-84. PubMed ID: 22385507
[TBL] [Abstract][Full Text] [Related]
4. PDE7-Selective and Dual Inhibitors: Advances in Chemical and Biological Research.
Jankowska A; Swierczek A; Chlon-Rzepa G; Pawlowski M; Wyska E
Curr Med Chem; 2017; 24(7):673-700. PubMed ID: 28093982
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, Anti-inflammatory Activity and Docking Studies of Some Newer 1,3-Thiazolidine-2,4-dione Derivatives as Dual Inhibitors of PDE4 and PDE7.
Sharma H; Lather V; Grewal AS; Pandita D
Curr Comput Aided Drug Des; 2019; 15(3):225-234. PubMed ID: 30280674
[TBL] [Abstract][Full Text] [Related]
6. Identification of potent pyrimidine inhibitors of phosphodiesterase 7 (PDE7) and their ability to inhibit T cell proliferation.
Guo J; Watson A; Kempson J; Carlsen M; Barbosa J; Stebbins K; Lee D; Dodd J; Nadler SG; McKinnon M; Barrish J; Pitts WJ
Bioorg Med Chem Lett; 2009 Apr; 19(7):1935-8. PubMed ID: 19272774
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and evaluation of quinazoline derivatives as phosphodiesterase 7 inhibitors.
Sánchez AI; Martínez-Barrasa V; Burgos C; Vaquero JJ; Alvarez-Builla J; Terricabras E; Segarra V
Bioorg Med Chem; 2013 Apr; 21(8):2370-2378. PubMed ID: 23454131
[TBL] [Abstract][Full Text] [Related]
8. Unraveling phosphodiesterase surfaces. Identification of phosphodiesterase 7 allosteric modulation cavities.
Redondo M; Soteras I; Brea J; González-García A; Cadavid MI; Loza MI; Martinez A; Gil C; Campillo NE
Eur J Med Chem; 2013; 70():781-8. PubMed ID: 24239625
[TBL] [Abstract][Full Text] [Related]
9. Discovery and SAR study of 2-(4-pyridylamino)thieno[3,2-d]pyrimidin-4(3H)-ones as soluble and highly potent PDE7 inhibitors.
Endo Y; Kawai K; Asano T; Amano S; Asanuma Y; Sawada K; Ogura K; Nagata N; Ueo N; Takahashi N; Sonoda Y; Kamei N
Bioorg Med Chem Lett; 2015 Feb; 25(3):649-53. PubMed ID: 25529739
[TBL] [Abstract][Full Text] [Related]
10. New methods for the discovery and synthesis of PDE7 inhibitors as new drugs for neurological and inflammatory disorders.
Safavi M; Baeeri M; Abdollahi M
Expert Opin Drug Discov; 2013 Jun; 8(6):733-51. PubMed ID: 23570245
[TBL] [Abstract][Full Text] [Related]
11. Spiroquinazolinones as novel, potent, and selective PDE7 inhibitors. Part 1.
Lorthiois E; Bernardelli P; Vergne F; Oliveira C; Mafroud AK; Proust E; Heuze L; Moreau F; Idrissi M; Tertre A; Bertin B; Coupe M; Wrigglesworth R; Descours A; Soulard P; Berna P
Bioorg Med Chem Lett; 2004 Sep; 14(18):4623-6. PubMed ID: 15324876
[TBL] [Abstract][Full Text] [Related]
12. Isothiazole and isoxazole fused pyrimidones as PDE7 inhibitors: SAR and pharmacokinetic evaluation.
Banerjee A; Yadav PS; Bajpai M; Sangana RR; Gullapalli S; Gudi GS; Gharat LA
Bioorg Med Chem Lett; 2012 May; 22(9):3223-8. PubMed ID: 22487174
[TBL] [Abstract][Full Text] [Related]
13. New classes of PDE7 inhibitors identified by a fission yeast-based HTS.
Alaamery MA; Wyman AR; Ivey FD; Allain C; Demirbas D; Wang L; Ceyhan O; Hoffman CS
J Biomol Screen; 2010 Apr; 15(4):359-67. PubMed ID: 20228279
[TBL] [Abstract][Full Text] [Related]
14. Discovery of 2-(cyclopentylamino)thieno[3,2-d]pyrimidin-4(3H)-one derivatives as a new series of potent phosphodiesterase 7 inhibitors.
Kawai K; Endo Y; Asano T; Amano S; Sawada K; Ueo N; Takahashi N; Sonoda Y; Nagai M; Kamei N; Nagata N
J Med Chem; 2014 Dec; 57(23):9844-54. PubMed ID: 25383422
[TBL] [Abstract][Full Text] [Related]
15. Novel cyclic compounds as potent phosphodiesterase 4 inhibitors.
He W; Huang FC; Hanney B; Souness J; Miller B; Liang G; Mason J; Djuric S
J Med Chem; 1998 Oct; 41(22):4216-23. PubMed ID: 9784096
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, structural analysis, and biological evaluation of thioxoquinazoline derivatives as phosphodiesterase 7 inhibitors.
Castaño T; Wang H; Campillo NE; Ballester S; González-García C; Hernández J; Pérez C; Cuenca J; Pérez-Castillo A; Martínez A; Huertas O; Gelpí JL; Luque FJ; Ke H; Gil C
ChemMedChem; 2009 May; 4(5):866-76. PubMed ID: 19350606
[TBL] [Abstract][Full Text] [Related]
17. Fused pyrimidine based inhibitors of phosphodiesterase 7 (PDE7): synthesis and initial structure-activity relationships.
Kempson J; Pitts WJ; Barbosa J; Guo J; Omotoso O; Watson A; Stebbins K; Starling GC; Dodd JH; Barrish JC; Felix R; Fischer K
Bioorg Med Chem Lett; 2005 Apr; 15(7):1829-33. PubMed ID: 15780616
[TBL] [Abstract][Full Text] [Related]
18. Phosphodiesterase 7 inhibition induces dopaminergic neurogenesis in hemiparkinsonian rats.
Morales-Garcia JA; Alonso-Gil S; Gil C; Martinez A; Santos A; Perez-Castillo A
Stem Cells Transl Med; 2015 Jun; 4(6):564-75. PubMed ID: 25925836
[TBL] [Abstract][Full Text] [Related]
19. Cloning, stable expression of human phosphodiesterase 7A and development of an assay for screening of PDE7 selective inhibitors.
Malik R; Bora RS; Gupta D; Sharma P; Arya R; Chaudhary S; Saini KS
Appl Microbiol Biotechnol; 2008 Jan; 77(5):1167-73. PubMed ID: 17952431
[TBL] [Abstract][Full Text] [Related]
20. Novel butanehydrazide derivatives of purine-2,6-dione as dual PDE4/7 inhibitors with potential anti-inflammatory activity: Design, synthesis and biological evaluation.
Chłoń-Rzepa G; Jankowska A; Ślusarczyk M; Świerczek A; Pociecha K; Wyska E; Bucki A; Gawalska A; Kołaczkowski M; Pawłowski M
Eur J Med Chem; 2018 Feb; 146():381-394. PubMed ID: 29407965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
